2 results
ACEi/ARBs in COVID-19: Beneficial, Bad, or Benign?
Preclinical studies suggest ACEi/ARB use increases ACE2 expression, raising concern
ACEi/ARBs in COVID ... David Rink, MS4 ... Kerryn Roome, MS4 ... #ARBs #COVID19 ... #Coronavirus #Pathophysiology
2021 ACR Guidance for Adjusting Immunomodulatory Therapy related to the COVID-19 Vaccine in Patients with Rheumatic
related to the COVID ... with Rheumatic & MSK ... @MithuRheum #ACR2021 ... #Guidelines #COVID19 ... #management #rheumatology